Marlene Mekel

930 total citations
18 papers, 614 citations indexed

About

Marlene Mekel is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Marlene Mekel has authored 18 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Marlene Mekel's work include Synthesis and biological activity (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Marlene Mekel is often cited by papers focused on Synthesis and biological activity (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Marlene Mekel collaborates with scholars based in United States, Netherlands and Israel. Marlene Mekel's co-authors include Richard Walter, A.G. Evdokimov, Matthew Pokross, Shengde Wu, Angelique Boyer, Namal C. Warshakoon, Richard M. Kawamoto, Richard L. Walter, Biswanath De and M. Sabat and has published in prestigious journals such as Biochemistry, Developmental Biology and Journal of Investigative Dermatology.

In The Last Decade

Marlene Mekel

18 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marlene Mekel United States	15	299	217	126	82	55	18	614
Masanori Tobe Japan	18	286 1.0×	508 2.3×	74 0.6×	60 0.7×	95 1.7×	32	933
Matthew G. LaPorte United States	17	237 0.8×	429 2.0×	27 0.2×	74 0.9×	19 0.3×	37	711
Jacques Eustache France	21	547 1.8×	894 4.1×	32 0.3×	57 0.7×	98 1.8×	56	1.3k
Prabhu Thirusangu India	20	430 1.4×	343 1.6×	164 1.3×	59 0.7×	64 1.2×	35	879
Ewa Żesławska Poland	14	267 0.9×	300 1.4×	135 1.1×	12 0.1×	36 0.7×	62	702
Rongze Kuang United States	16	280 0.9×	320 1.5×	145 1.2×	25 0.3×	39 0.7×	27	592
Moritz Werder Switzerland	17	694 2.3×	311 1.4×	76 0.6×	30 0.4×	12 0.2×	22	1.2k
Susan E. Draheim United States	14	391 1.3×	289 1.3×	61 0.5×	32 0.4×	102 1.9×	21	727
Paul F. van Swieten Netherlands	10	366 1.2×	272 1.3×	22 0.2×	22 0.3×	9 0.2×	12	568
Philip N. Edwards United Kingdom	15	262 0.9×	239 1.1×	73 0.6×	79 1.0×	50 0.9×	25	588

Countries citing papers authored by Marlene Mekel

Since Specialization

Citations

This map shows the geographic impact of Marlene Mekel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlene Mekel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlene Mekel more than expected).

Fields of papers citing papers by Marlene Mekel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlene Mekel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlene Mekel. The network helps show where Marlene Mekel may publish in the future.

Co-authorship network of co-authors of Marlene Mekel

This figure shows the co-authorship network connecting the top 25 collaborators of Marlene Mekel. A scholar is included among the top collaborators of Marlene Mekel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlene Mekel. Marlene Mekel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Gao, Yuanyuan, Diane S. Sepich, Bo Hu, et al.. (2021). CARMIL3 is important for cell migration and morphogenesis during early development in zebrafish. Developmental Biology. 481. 148–159. 4 indexed citations

McConnell, Patrick, Marlene Mekel, Alexander G. Kozlov, et al.. (2020). Comparative Analysis of CPI-Motif Regulation of Biochemical Functions of Actin Capping Protein. Biochemistry. 59(11). 1202–1215. 11 indexed citations

Johnson, Britney, Patrick McConnell, Marlene Mekel, et al.. (2018). Allosteric Coupling of CARMIL and V-1 Binding to Capping Protein Revealed by Hydrogen-Deuterium Exchange. Cell Reports. 23(9). 2795–2804. 15 indexed citations

Almog, Orna, Ana González‐García, Marlene Mekel, et al.. (2008). The crystal structures of the psychrophilic subtilisin S41 and the mesophilic subtilisin Sph reveal the same calcium‐loaded state. Proteins Structure Function and Bioinformatics. 74(2). 489–496. 24 indexed citations

DeAngelis, Yvonne M., Charles W. Saunders, Nancy L. Reeder, et al.. (2007). Isolation and Expression of a Malassezia globosa Lipase Gene, LIP1. Journal of Investigative Dermatology. 127(9). 2138–2146. 111 indexed citations

Warshakoon, Namal C., Shengde Wu, Angelique Boyer, et al.. (2006). Structure-based design, synthesis, and SAR evaluation of a new series of 8-hydroxyquinolines as HIF-1α prolyl hydroxylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(21). 5517–5522. 49 indexed citations

Warshakoon, Namal C., Shengde Wu, Angelique Boyer, et al.. (2006). A novel series of imidazo[1,2-a]pyridine derivatives as HIF-1α prolyl hydroxylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(21). 5598–5601. 52 indexed citations

Sabat, M., John C. VanRens, Matthew J. Laufersweiler, et al.. (2006). The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck). Bioorganic & Medicinal Chemistry Letters. 16(23). 5973–5977. 57 indexed citations

Evdokimov, A.G., Matthew Pokross, Richard Walter, et al.. (2006). Engineering the catalytic domain of human protein tyrosine phosphatase β for structure-based drug discovery. Acta Crystallographica Section D Biological Crystallography. 62(12). 1435–1445. 22 indexed citations

10.

Hopkins, Corey R., Steven V. O’Neil, Michael C. Laufersweiler, et al.. (2006). Design and synthesis of novel N-sulfonyl-2-indole carboxamides as potent PPAR-γ binding agents with potential application to the treatment of osteoporosis. Bioorganic & Medicinal Chemistry Letters. 16(21). 5659–5663. 42 indexed citations

11.

Sabat, M., John C. VanRens, Michael P. Clark, et al.. (2006). The development of novel C-2, C-8, and N-9 trisubstituted purines as inhibitors of TNF-α production. Bioorganic & Medicinal Chemistry Letters. 16(16). 4360–4365. 11 indexed citations

12.

Brugel, Todd A., Jennifer A. Maier, Michael P. Clark, et al.. (2006). Development of N-2,4-pyrimidine-N-phenyl-N′-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 1. Bioorganic & Medicinal Chemistry Letters. 16(13). 3510–3513. 15 indexed citations

13.

Warshakoon, Namal C., Shengde Wu, Angelique Boyer, et al.. (2006). Design and synthesis of a series of novel pyrazolopyridines as HIF 1-α prolyl hydroxylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(21). 5687–5690. 68 indexed citations

14.

Warshakoon, Namal C., Shengde Wu, Angelique Boyer, et al.. (2006). Design and synthesis of substituted pyridine derivatives as HIF-1α prolyl hydroxylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(21). 5616–5620. 29 indexed citations

15.

Evdokimov, A.G., Matthew Pokross, Richard L. Walter, et al.. (2006). Serendipitous discovery of novel bacterial methionine aminopeptidase inhibitors. Proteins Structure Function and Bioinformatics. 66(3). 538–546. 18 indexed citations

16.

Clark, Michael P., Adam Gołȩbiowski, Todd A. Brugel, et al.. (2005). The development of new isoxazolone based inhibitors of tumor necrosis factor-alpha (TNF-α) production. Bioorganic & Medicinal Chemistry Letters. 15(9). 2399–2403. 49 indexed citations

17.

Gołȩbiowski, Adam, Matthew J. Laufersweiler, Todd A. Brugel, et al.. (2005). The development of monocyclic pyrazolone based cytokine synthesis inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(9). 2285–2289. 20 indexed citations

18.

Laufersweiler, Matthew J., Todd A. Brugel, Michael P. Clark, et al.. (2004). The development of novel inhibitors of tumor necrosis factor-α (TNF-α) production based on substituted [5,5]-bicyclic pyrazolones. Bioorganic & Medicinal Chemistry Letters. 14(16). 4267–4272. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact